ALLIANCEBERNSTEIN L.P. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 135 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$6,068,381
+110.8%
131,950
+163.5%
0.00%
+200.0%
Q2 2023$2,878,098
+70.9%
50,080
+11.5%
0.00%0.0%
Q1 2023$1,683,638
-25.3%
44,897
-44.2%
0.00%0.0%
Q4 2022$2,254,041
+58.8%
80,444
+59.3%
0.00%0.0%
Q3 2022$1,419,000
-19.0%
50,489
+0.3%
0.00%0.0%
Q2 2022$1,752,000
+5.6%
50,347
+9.0%
0.00%0.0%
Q1 2022$1,659,000
+54.6%
46,206
+0.3%
0.00%
Q4 2021$1,073,000
-35.8%
46,053
-47.6%
0.00%
-100.0%
Q3 2021$1,672,000
+74.0%
87,935
+84.5%
0.00%
Q2 2021$961,000
+10.1%
47,6700.0%0.00%
Q1 2021$873,000
-51.7%
47,670
-47.0%
0.00%
-100.0%
Q4 2020$1,808,000
+8.6%
89,883
+1.2%
0.00%0.0%
Q3 2020$1,665,000
-31.4%
88,810
-17.8%
0.00%0.0%
Q2 2020$2,426,000
+51.1%
108,010
-0.2%
0.00%0.0%
Q1 2020$1,606,000
-23.9%
108,190
-1.1%
0.00%0.0%
Q4 2019$2,109,000
-1.4%
109,340
+1.3%
0.00%0.0%
Q3 2019$2,140,000
-12.8%
107,940
-7.1%
0.00%
-50.0%
Q2 2019$2,453,000
+17.9%
116,190
+14.1%
0.00%
+100.0%
Q1 2019$2,080,000
-15.0%
101,790
-17.2%
0.00%
-50.0%
Q4 2018$2,446,000
+2.4%
122,900
-1.0%
0.00%0.0%
Q3 2018$2,388,000
+26.1%
124,1000.0%0.00%
+100.0%
Q2 2018$1,894,000
-2.5%
124,100
+19.8%
0.00%0.0%
Q1 2018$1,942,000
-11.1%
103,570
-8.8%
0.00%
-50.0%
Q4 2017$2,184,000
+168.0%
113,520
+148.9%
0.00%
+100.0%
Q3 2017$815,000
+0.1%
45,6000.0%0.00%0.0%
Q2 2017$814,000
+1.0%
45,600
-18.0%
0.00%0.0%
Q1 2017$806,000
-81.0%
55,600
-75.9%
0.00%
-75.0%
Q4 2016$4,243,000
+4.3%
230,330
+7.4%
0.00%
+33.3%
Q3 2016$4,068,000
+138.9%
214,420
+103.0%
0.00%
+200.0%
Q2 2016$1,703,000
+261.6%
105,630
+169.1%
0.00%
Q1 2016$471,000
+14.0%
39,260
+35.3%
0.00%
Q4 2015$413,000
+22.9%
29,020
+1.1%
0.00%
Q3 2015$336,000
-23.6%
28,700
+14.8%
0.00%
Q2 2015$440,000
+303.7%
25,000
+242.5%
0.00%
Q1 2015$109,0007,3000.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2018
NameSharesValueWeighting ↓
EAM Investors, LLC 173,018$3,187,0000.42%
GLOBEFLEX CAPITAL L P 50,686$934,0000.23%
KALMAR INVESTMENTS INC /DE/ 240,648$4,433,0000.23%
ESSEX INVESTMENT MANAGEMENT CO LLC 63,661$1,173,0000.19%
OBERWEIS ASSET MANAGEMENT INC/ 27,200$501,0000.15%
Invictus RG 11,950$220,0000.15%
ACADIAN ASSET MANAGEMENT LLC 1,502,151$27,668,0000.13%
FOX RUN MANAGEMENT, L.L.C. 12,600$232,0000.12%
Piermont Capital Management Inc. 26,153$482,0000.11%
FEDERATED HERMES, INC. 1,344,684$24,769,0000.07%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders